Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1411 AL 1425

Genetics and genomics of Parkinson's disease

Lin MK, Farrer MJ.

Genome Med. 2014 Jun 30;6(6):48. doi: 10.1186/gm566. eCollection 2014.

Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trial

Jennings D, Eberly S, Oakes D, Seibyl J, Marek K, Shoulson I; Parkinson Study Group PRECEPT Investigators.

J Parkinsons Dis. 2014;4(4):629-38. doi: 10.3233/JPD-140383.

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R; International Parkinson's Disease Genomics Consortium (IPDGC); Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI); 23andMe; GenePD; NeuroGenetics Research Consortium (NGRC); Hussman Institute of Human Genomics (HIHG); Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC); Greek Parkinson's Disease Consortium; Alzheimer Genetic Analysis Group; Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB.

Nat Genet. 2014 Sep;46(9):989-93. doi: 10.1038/ng.3043. Epub 2014 Jul 27.

Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives

Veenvliet JV, Smidt MP.

Cell Mol Life Sci. 2014 Dec;71(24):4703-27. doi: 10.1007/s00018-014-1681-5. Epub 2014 Jul 27.

Reliability of the Japanese version of the scales for outcomes in Parkinson's disease-autonomic questionnaire

Matsushima M, Yabe I, Hirotani M, Kano T, Sasaki H.

Clin Neurol Neurosurg. 2014 Sep;124:182-4. doi: 10.1016/j.clineuro.2014.07.007. Epub 2014 Jul 15.

Giant Virchow-Robin spaces as an incidental finding in a patient with parkinsonism

Omidi SJ, Moghadam HN, Ghorbani A, Fatehi F.

Arch Iran Med. 2014 Aug;17(8):587-8.

Idiopathic basal ganglia calcification as a differential diagnosis of parkinsonism: a case report in an older adult

Rocha-Balcazar J, Perez-Zepeda M.

Geriatr Gerontol Int. 2014 Jul;14(3):724-5. doi: 10.1111/ggi.12173.

Direct and indirect pathways of basal ganglia: a critical reappraisal

Calabresi P, Picconi B, Tozzi A, Ghiglieri V, Di Filippo M.

Nat Neurosci. 2014 Aug;17(8):1022-30. doi: 10.1038/nn.3743. Epub 2014 Jul 28.

Functional polymorphisms of the MAO gene with Parkinson disease susceptibility: a meta-analysis

Sun YX, Wang XH, Xu AH, Zhao JH.

J Neurol Sci. 2014 Oct 15;345(1-2):97-105. doi: 10.1016/j.jns.2014.07.016. Epub 2014 Jul 15.

Ascorbate- and zinc-responsive parkinsonism

Quiroga MJ, Carroll DW, Brown TM.

Ann Pharmacother. 2014 Nov;48(11):1515-20. doi: 10.1177/1060028014545356. Epub 2014 Jul 28.

Interaction of LRRK2 with kinase and GTPase signaling cascades

Boon JY, Dusonchet J, Trengrove C, Wolozin B.

Front Mol Neurosci. 2014 Jul 9;7:64. doi: 10.3389/fnmol.2014.00064. eCollection 2014.

Brain renin-angiotensin system and dopaminergic cell vulnerability

Labandeira-García JL, Garrido-Gil P, Rodriguez-Pallares J, Valenzuela R, Borrajo A, Rodríguez-Perez AI.

Front Neuroanat. 2014 Jul 8;8:67. doi: 10.3389/fnana.2014.00067. eCollection 2014.

Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development

Le Foll B, Wilson AA, Graff A, Boileau I, Di Ciano P.

Front Pharmacol. 2014 Jul 10;5:161. doi: 10.3389/fphar.2014.00161. eCollection 2014.

Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants

Hornik CP, Chu PY, Li JS, Clark RH, Smith PB, Hill KD.

Pediatr Crit Care Med. 2014 Nov;15(9):839-45. doi: 10.1097/PCC.0000000000000229.

Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?

Beekes M, Thomzig A, Schulz-Schaeffer WJ, Burger R.

Acta Neuropathol. 2014 Oct;128(4):463-76. doi: 10.1007/s00401-014-1324-9. Epub 2014 Jul 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias